Empagliflozin treatment differentially modifies visceral and subcutaneous adipose tissue lipidomes and pro-inflammatory cytokines in zucker fatty diabetic rats.

28 August 2022 (12:15 - 13:00)
Organised by:
Congress Presentation Part of: Metabolism, mitochondria, and heart diseases Metabolism ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by